Toronto Dominion Bank Acquires 21,079 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Toronto Dominion Bank grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 11.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 202,571 shares of the medical equipment provider's stock after buying an additional 21,079 shares during the period. Toronto Dominion Bank owned approximately 0.06% of Intuitive Surgical worth $105,734,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. M.E. Allison & CO. Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $449,000. Seilern Investment Management Ltd acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $82,517,000. Sycomore Asset Management grew its holdings in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after buying an additional 4,079 shares during the period. China Universal Asset Management Co. Ltd. grew its holdings in shares of Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock valued at $5,138,000 after buying an additional 525 shares during the period. Finally, Truist Financial Corp grew its holdings in shares of Intuitive Surgical by 3.0% in the 4th quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider's stock valued at $129,494,000 after buying an additional 7,298 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $4.47 during midday trading on Tuesday, reaching $557.16. 1,233,924 shares of the company's stock were exchanged, compared to its average volume of 1,644,790. Intuitive Surgical, Inc. has a 52 week low of $396.15 and a 52 week high of $616.00. The firm has a market cap of $199.70 billion, a price-to-earnings ratio of 86.92, a P/E/G ratio of 5.85 and a beta of 1.70. The stock's 50-day simple moving average is $508.11 and its 200 day simple moving average is $537.36.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the previous year, the business earned $1.50 earnings per share. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,700 shares of company stock valued at $16,865,621. 0.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on ISRG shares. Truist Financial dropped their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Bernstein Bank lifted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday, January 27th. Jefferies Financial Group lifted their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Wells Fargo & Company lifted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Finally, Piper Sandler dropped their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus price target of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.